← Back to headlines

RESET-R Trial: One or Two Cycles of Nivolumab + Ipilimumab in dMMR Rectal Cancer

This story is reported by Oncodaily. Read what other outlets are saying below, then open the original report for full details.

RESET-R Trial: One or Two Cycles of Nivolumab + Ipilimumab in dMMR Rectal Cancer · NabkaNews